Resources

Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications

Biotechnology & genetic engineering reviews, Vol. 38, Issue 2, Pages 339-383, 2022

PMID: 35968863

Tissue biopsy analysis has conventionally been the gold standard for cancer prognosis, diagnosis and prediction of responses/resistances to treatments. The existing biopsy procedures used in clinical practice are, however, invasive, painful and often associated with pitfalls like poor recovery of tumor cells and infeasibility for repetition in single patients.

Read More

  https://www.ncbi.nlm.nih.gov/pubmed/35968863

 

Considering Genomic Research?

    Fields marked in * is mandatory to fill
     
     
     

    2024 © MedGenome • All Rights Reserved
    Request a Quote